175 related articles for article (PubMed ID: 10188846)
1. Diagnosis: atypical fibroxanthoma or not? Evaluating spindle cell malignancies on sun damaged skin: a practical approach.
Heintz PW; White CR
Semin Cutan Med Surg; 1999 Mar; 18(1):78-83. PubMed ID: 10188846
[TBL] [Abstract][Full Text] [Related]
2. Spindle cell neoplasm of skin: diagnostic dilemma.
Jain M; Singh S; Agarwal K
Indian J Pathol Microbiol; 2007 Oct; 50(4):814-6. PubMed ID: 18306566
[TBL] [Abstract][Full Text] [Related]
3. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
4. Clear cell atypical fibroxanthoma:a clinicopathologic study.
Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
[TBL] [Abstract][Full Text] [Related]
5. P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin.
Sigal AC; Keenan M; Lazova R
Am J Dermatopathol; 2012 Apr; 34(2):145-50. PubMed ID: 22207443
[TBL] [Abstract][Full Text] [Related]
6. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
8. Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.
Brenn T
Head Neck Pathol; 2020 Mar; 14(1):109-120. PubMed ID: 31950467
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma in a young female misdiagnosed clinically as a malignant melanoma--An unusual presentation.
Pujani M; Hassan MJ; Jetley S
J Cancer Res Ther; 2015; 11(4):1027. PubMed ID: 26881598
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
11. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies.
Henderson SA; Torres-Cabala CA; Curry JL; Bassett RL; Ivan D; Prieto VG; Tetzlaff MT
Am J Surg Pathol; 2014 Aug; 38(8):1102-10. PubMed ID: 25029117
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous sarcomas and sarcomatoid neoplasms of the skin.
Wick MR; Fitzgibbon J; Swanson PE
Semin Diagn Pathol; 1993 May; 10(2):148-58. PubMed ID: 8396271
[TBL] [Abstract][Full Text] [Related]
14. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
[TBL] [Abstract][Full Text] [Related]
15. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report.
Smith-Zagone MJ; Prieto VG; Hayes RA; Timperman WW; Diwan AH
J Cutan Pathol; 2004 Mar; 31(3):284-6. PubMed ID: 14984584
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma detected by high-molecular-weight cytokeratin immunostaining mimicking atypical fibroxanthoma.
Gray Y; Robidoux HJ; Farrell DS; Robinson-Bostom L
Arch Pathol Lab Med; 2001 Jun; 125(6):799-802. PubMed ID: 11371235
[TBL] [Abstract][Full Text] [Related]
17. Melanoma simulating atypical fibroxanthoma.
Sangüeza M; Zelger B
Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
[TBL] [Abstract][Full Text] [Related]
18. h-caldesmon immunoreactivity in atypical fibroxanthoma: implications for the differential diagnosis.
Martinez-Ciarpaglini C; Agustí J; Alvarez E; Hueso L; Terrádez L; Monteagudo C
Pathology; 2018 Apr; 50(3):358-361. PubMed ID: 29490873
[No Abstract] [Full Text] [Related]
19. Could cathepsin-k be a driver of the myofibroblastic differentiation observed in dermatofibroma, atypical fibroxanthoma and pleomorphic dermal sarcoma?
Ricci C; De Leo A; Dika E; Lambertini M; Veronesi G; Corti B
Acta Histochem; 2020 Feb; 122(2):151498. PubMed ID: 31889532
[TBL] [Abstract][Full Text] [Related]
20. Spindle-cell non-pleomorphic atypical fibroxanthoma: analysis of a series and delineation of a distinctive variant.
Calonje E; Wadden C; Wilson-Jones E; Fletcher CD
Histopathology; 1993 Mar; 22(3):247-54. PubMed ID: 7684354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
